94 related articles for article (PubMed ID: 28724203)
1. Huprine X Attenuates The Neurotoxicity Induced by Kainic Acid, Especially Brain Inflammation.
Relat J; Pérez B; Camps P; Muñoz-Torrero D; Badia A; Victòria Clos M
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):94-103. PubMed ID: 28724203
[TBL] [Abstract][Full Text] [Related]
2. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice.
Relat J; Come J; Perez B; Camps P; Muñoz-Torrero D; Badia A; Gimenez-Llort L; Clos MV
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181440
[TBL] [Abstract][Full Text] [Related]
4. Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD).
Ratia M; Giménez-Llort L; Camps P; Muñoz-Torrero D; Pérez B; Clos MV; Badia A
Neurodegener Dis; 2013; 11(3):129-40. PubMed ID: 22626981
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects and regulation of PKCalpha and MAPK by huprine X in middle aged mice.
Ratia M; Giménez-Llort L; Camps P; Muñoz-Torrero D; Clos MV; Badia A
Pharmacol Biochem Behav; 2010 Jun; 95(4):485-93. PubMed ID: 20363245
[TBL] [Abstract][Full Text] [Related]
6. AVCRI104P3, a novel multitarget compound with cognition-enhancing and anxiolytic activities: studies in cognitively poor middle-aged mice.
Giménez-Llort L; Ratia M; Pérez B; Camps P; Muñoz-Torrero D; Badia A; Clos MV
Behav Brain Res; 2015 Jun; 286():97-103. PubMed ID: 25732954
[TBL] [Abstract][Full Text] [Related]
7. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
Camps P; Cusack B; Mallender WD; El Achab RE; Morral J; Muñoz-Torrero D; Rosenberry TL
Mol Pharmacol; 2000 Feb; 57(2):409-17. PubMed ID: 10648652
[TBL] [Abstract][Full Text] [Related]
8. The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity.
Gleeson LC; Ryan KJ; Griffin EW; Connor TJ; Harkin A
Brain Behav Immun; 2010 Nov; 24(8):1354-61. PubMed ID: 20599496
[TBL] [Abstract][Full Text] [Related]
9. (+/-)-huprine Y, (-)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration.
Jordá EG; Verdaguer E; Jiménez A; Canudas AM; Rimbau V; Camps P; Muñoz-Torrero D; Camins A; Pallàs M
J Alzheimers Dis; 2004 Dec; 6(6):577-83; discussion 673-81. PubMed ID: 15665397
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damage.
Canudas AM; Pubill D; Sureda FX; Verdaguer E; Camps P; Muñoz-Torrero D; Jiménez A; Camins A; Pallàs M
Exp Neurol; 2003 Apr; 180(2):123-30. PubMed ID: 12684026
[TBL] [Abstract][Full Text] [Related]
11. Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.
Cho IH; Kim SW; Kim JB; Kim TK; Lee KW; Han PL; Lee JK
J Neurosci Res; 2006 Nov; 84(7):1505-11. PubMed ID: 16958132
[TBL] [Abstract][Full Text] [Related]
12. Protracted exposure to supraphysiological levels of corticosterone does not cause neuronal loss or damage and protects against kainic acid-induced neurotoxicity in the hippocampus of C57BL/6J mice.
Benkovic SA; O'Callaghan JP; Miller DB
Neurotoxicology; 2009 Nov; 30(6):965-76. PubMed ID: 19616023
[TBL] [Abstract][Full Text] [Related]
13. Hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats.
Chang CY; Lin TY; Lu CW; Huang SK; Wang YC; Chou SS; Wang SJ
Neurotoxicology; 2015 Sep; 50():157-69. PubMed ID: 26342684
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
Roman S; Badia A; Camps P; Muñoz-Torrero D; Clos MV
Brain Res; 2005 Nov; 1061(2):73-9. PubMed ID: 16248990
[TBL] [Abstract][Full Text] [Related]
15. Screening of new huprines--inhibitors of acetylcholinesterases by electrospray ionization ion trap mass spectrometry.
Ziemianin A; Ronco C; Dolé R; Jean L; Renard PY; Lange CM
J Pharm Biomed Anal; 2012 Nov; 70():1-5. PubMed ID: 22677656
[TBL] [Abstract][Full Text] [Related]
16. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of 2,2'-dithienyl diselenide on kainic acid-induced neurotoxicity in rat hippocampus.
Bortolatto CF; Jesse CR; Wilhelm EA; Ribeiro LR; Rambo LM; Royes LF; Roman SS; Nogueira CW
Neuroscience; 2011 Oct; 193():300-9. PubMed ID: 21820494
[TBL] [Abstract][Full Text] [Related]
18. Potential pharmacological strategies for the improved treatment of organophosphate-induced neurotoxicity.
Kaur S; Singh S; Chahal KS; Prakash A
Can J Physiol Pharmacol; 2014 Nov; 92(11):893-911. PubMed ID: 25348489
[TBL] [Abstract][Full Text] [Related]
19. New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors.
Ronco C; Foucault R; Gillon E; Bohn P; Nachon F; Jean L; Renard PY
ChemMedChem; 2011 May; 6(5):876-88. PubMed ID: 21344648
[TBL] [Abstract][Full Text] [Related]
20. Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography.
Ronco C; Carletti E; Colletier JP; Weik M; Nachon F; Jean L; Renard PY
ChemMedChem; 2012 Mar; 7(3):400-5. PubMed ID: 22052791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
